| Kite Pharma Announces Proposed Public Offering of Common Stock (NASDAQ:KITE) |
kmedin14 |
Dec 16, 2015 11:39:14 AM |
| Investor Relations |
kmedin14 |
Dec 16, 2015 11:13:03 AM |
| Novartis' leading CAR-T cancer therapy gains breakthrough status at the FDA |
kmedin14 |
Dec 16, 2015 10:36:44 AM |
| Juno’s Investigational CAR T Cell Product Candidates JCAR014 and JCAR018 Demonstrate Encouraging Clinical Responses in Patients with B-Cell Cancers |
kmedin14 |
Dec 16, 2015 10:36:40 AM |
| Healthcare – Google Finance |
kmedin14 |
Dec 16, 2015 10:35:29 AM |
| Kite Pharma 10-Q |
kmedin14 |
Dec 16, 2015 10:29:16 AM |
| Kite Pharma, Inc. |
kmedin14 |
Dec 16, 2015 9:53:54 AM |
| Kite Pharma Names David Chang, M.D., Ph.D., to Lead R&D Programs (NASDAQ:KITE) |
kmedin14 |
Dec 16, 2015 9:31:09 AM |
| Kite Pharma Appoints Keith Nolop, M.D. Chief Medical Officer (NASDAQ:KITE) |
kmedin14 |
Dec 16, 2015 9:28:57 AM |
| Kite Pharma Announces the Appointment of Arie Belldegrun, M.D., as President and Chief Executive Officer (NASDAQ:KITE) |
kmedin14 |
Dec 16, 2015 8:46:51 AM |
